Infervision company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

infervision.com

Founded Year

2015

Stage

Series D - II | Alive

Total Raised

$210.39M

Valuation

$0000 

Last Raised

$94.94M | 1 yr ago

About Infervision

Infervision is a global high-tech enterprise in medical artificial intelligence, aiming to empower doctors with higher efficiency and benefit patients with better diagnosis, outcome, and lower cost. Infervision provides products and services to providers, and patients; with robust A.I. solutions fully integrated with the healthcare workflow to help diagnosing various diseases and conditions such as cerebral hemorrhage, lung cancer, bone fractures, emphysema, and more. Infervision also provides an AI-powered research platform for medical professionals with any research directions and needs.

Infervision Headquarters Location

18 / F, Seat E Ocean international Center, Chaoyang District

Beijing, Beijing,

China

ESPs containing Infervision

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Life Sciences / Medical Devices Tech

Computer-aided diagnostic imaging utilizes algorithms to detect, extract, and communicate data from medical images more efficiently and accurately than the human eye. The technology is being deployed across several imaging modalities to improve the detection, diagnosis, triaging, and, ultimately, the prognosis of various medical conditions.

Infervision named as Highflier among 14 other companies, including PathAI, Ibex Medical Analytics, and Aidoc Medical.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Infervision

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Infervision in 3 CB Insights research briefs, most recently on Feb 16, 2022.

Expert Collections containing Infervision

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Infervision is included in 8 Expert Collections, including Artificial Intelligence.

A

Artificial Intelligence

9,093 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

D

Digital Health

13,551 items

M

Medical Devices

11,981 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

H

Health Monitoring & Diagnostics

2,707 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

D

Digital Health 150

150 items

The winners of the second annual CB Insights Digital Health 150.

Infervision Patents

Infervision has filed 7 patents.

The 3 most popular patent topics include:

  • Artificial neural networks
  • Machine learning
  • Artificial intelligence
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/31/2016

12/14/2021

Artificial neural networks, Machine learning, Learning methods, Artificial intelligence, Deep learning

Grant

Application Date

5/31/2016

Grant Date

12/14/2021

Title

Related Topics

Artificial neural networks, Machine learning, Learning methods, Artificial intelligence, Deep learning

Status

Grant

Latest Infervision News

Infervision receives nod for AI-powered CT reader in China

Jul 13, 2022

July 13, 2022 Infervision Medical Technology Co. Ltd. received approval from China’s NMPA for its radiological computer-assisted triage and notification software device Inferread CT Stroke. This is the first class III approval that the firm obtained in the cerebro-cardiovascular field. Class III approvals are for high-risk medical devices.

Infervision Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Infervision Rank

  • When was Infervision founded?

    Infervision was founded in 2015.

  • Where is Infervision's headquarters?

    Infervision's headquarters is located at 18 / F, Seat E, Beijing.

  • What is Infervision's latest funding round?

    Infervision's latest funding round is Series D - II.

  • How much did Infervision raise?

    Infervision raised a total of $210.39M.

  • Who are the investors of Infervision?

    Investors of Infervision include V-Capital, Zhongguancun M&A Fund, Zhongguancun Science City Science and Technology Fund, New Alliance Capital, CCB Trust and 19 more.

  • Who are Infervision's competitors?

    Competitors of Infervision include Koios Medical, Cleerly, Lunit, Aidoc Medical, Viz.ai, Aidence, SenseTime, Overjet, Iterative Scopes, Aiforia and 29 more.

You May Also Like

Ultromics Logo
Ultromics

Ultromics is a global health technology company that provides autonomous echocardiography analysis through AI solutions – empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease. Its cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

A
Aidoc Medical

Aidoc finds and flags critical findings in medical images. By automatically prioritizing urgent, life-threatening conditions like intracranial hemorrhage and pulmonary embolism, Aidoc saves lives, improves patient care and cuts waiting time for the must urgent patients down to only a few minutes. The always-on AI integrates into a radiologist's workflow, reprioritizing cases without forcing radiologists to change the way they work. Aidoc was founded in 2016 and is based in Tel Aviv, Israel.

Koios Medical Logo
Koios Medical

Koios Medical is a provider of software solutions for radiologists diagnosing cancer. Using AI algorithms trained on thousands of images combined with data from pathology results, Koios DS™ is decision support for healthcare diagnostics. Koios Medical was formerly known as Clearview Diagnostics. The company was founded in 2012 and is based in Chicago, Illinois.

QUIBIM Logo
QUIBIM

Quibim, a company with its headquarters in Valencia, Spain, provides a whole-body medical imaging analysis. Quibim products are used worldwide by a huge diversity of research and care teams. Partners use Quibim Precision, a CE-marked whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy of treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers.

Viz.ai Logo
Viz.ai

Viz.ai aims to use artificial intelligence and deep learning to automatically identify suspected LVOs (large vessel occlusion) on CTA imaging with the aim of alerting a patient's physician within minutes. The company was founded in 2016 and is based in San Francisco, California.

Iterative Scopes Logo
Iterative Scopes

Iterative Scopes is a software-only gastrointestinal data company that is working to deliver AI toolkits to the practice of gastroenterology.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.